The severe acute respiratory syndrome coronavirus 3a is a novel structural protein
- 5 March 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 330 (1), 286-292
- https://doi.org/10.1016/j.bbrc.2005.02.153
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Use of Viral Lysate Antigen Combined with Recombinant Protein in Western Immunoblot Assay as Confirmatory Test for Serodiagnosis of Severe Acute Respiratory SyndromeClinical and Vaccine Immunology, 2004
- Efficient assembly and release of SARS coronavirus‐like particles by a heterologous expression systemFEBS Letters, 2004
- Disease‐Specific B Cell Epitopes for Serum Antibodies from Patients with Severe Acute Respiratory Syndrome (SARS) and Serologic Detection of SARS Antibodies by Epitope‐Based Peptide AntigensThe Journal of Infectious Diseases, 2004
- Characterization of the 3a Protein of SARS-associated Coronavirus in Infected Vero E6 Cells and SARS PatientsJournal of Molecular Biology, 2004
- Assembly of human severe acute respiratory syndrome coronavirus-like particlesBiochemical and Biophysical Research Communications, 2004
- Identification of a novel protein 3a from severe acute respiratory syndrome coronavirusFEBS Letters, 2004
- Profiles of Antibody Responses against Severe AcuteRespiratory Syndrome Coronavirus Recombinant Proteins andTheir Potential Use as DiagnosticMarkersClinical and Vaccine Immunology, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Identification of a New Membrane-associated Polypeptide Specified by the Coronavirus Infectious Bronchitis VirusJournal of General Virology, 1990